New Hemo Control uniquely ensures bi-directional data management future proofing EKF Diagnostics, the global diagnostics company, announces that it has launched its next generation Hemo Control ...

EKF Diagnostics, the global in vitro diagnostics company, announces that it is supporting the reduction of anemia in developing regions of South America through the use of its point-of-care (POC) ...

EKF Diagnostics has announced that the 33,333rd Hemo Control hemoglobin analyzer has been built at EKF’s manufacturing facility in Barleben, Germany. Providing lab quality results within 25 seconds ...

EKF Diagnostics Holdings plc (AIM: EKF), the AIM listed point-of-care, central laboratory and molecular diagnostics business, announces that it has recently won two new tenders for its Hemo Control ...

LONDON (Alliance News) - EKF Diagnostics Holdings PLC on Thursday said it has secured two new contracts for its Hemo Control point-of-care hemoglobin analyser in Turkey and the US. In Turkey, the ...

EKF Diagnostics, which is focused on the in-vitro diagnostic devices market, yesterday landed a £1m contract with the Peruvian Government. EKF Diagnostics, which is focused on the in-vitro diagnostic ...

EKF Diagnostics has launched its next generation Hemo Control point-of-care (POC) diagnostics analyzer, providing laboratory accurate hemoglobin and hematocrit results in one simple test. Uniquely the ...